Skip to Main Content

Author Details

Carol L Sabourin
Battelle Memorial Institute
1978
77
28
PMIDPaper TitleJournal TitlePublished Year
36016104Adapting Simon's Two-Stage Design for Efficient Screening of Filovirus Vaccines in Non-Human Primates.Vaccines (Basel)2022
35746571Natural History of <i>Sudan ebolavirus</i> to Support Medical Countermeasure Development.Vaccines (Basel)2022
36298846Natural History of Marburg Virus Infection to Support Medical Countermeasure Development.Viruses2022
34579282Selection of Filovirus Isolates for Vaccine Development Programs.Vaccines (Basel)2021
32841291Interlaboratory comparison for the Filovirus Animal Nonclinical Group (FANG) anti-Ebola virus glycoprotein immunoglobulin G enzyme-linked immunosorbent assay.PLoS One2020
31879781Characterization of Cholinesterases From Multiple Large Animal Species for Medical Countermeasure Development Against Chemical Warfare Nerve Agents.Toxicol Sci2020
33119638Method feasibility for cross-species testing, qualification, and validation of the Filovirus Animal Nonclinical Group anti-Ebola virus glycoprotein immunoglobulin G enzyme-linked immunosorbent assay for non-human primate serum samples.PLoS One2020
30998735Development, qualification, and validation of the Filovirus Animal Nonclinical Group anti-Ebola virus glycoprotein immunoglobulin G enzyme-linked immunosorbent assay for human serum samples.PLoS One2019
31480472Approach to Strain Selection and the Propagation of Viral Stocks for Venezuelan Equine Encephalitis Virus Vaccine Efficacy Testing under the Animal Rule.Viruses2019
29142131Single-Dose Trivalent VesiculoVax Vaccine Protects Macaques from Lethal Ebolavirus and Marburgvirus Challenge.J Virol2018
28630358Assessing the safety and immunogenicity of recombinant vesicular stomatitis virus Ebola vaccine in healthy adults: a randomized clinical trial.CMAJ2017
28225154Human butyrylcholinesterase efficacy against nerve agent exposure.J Biochem Mol Toxicol2017
26865594Humoral and Cell-Mediated Immune Responses to Alternate Booster Schedules of Anthrax Vaccine Adsorbed in Humans.Clin Vaccine Immunol2016
27170682Characterization of a Mouse Model of Oral Potassium Cyanide Intoxication.Int J Toxicol2016
27170681Neurobehavioral and Cardiovascular Effects of Potassium Cyanide Administered Orally to Mice.Int J Toxicol2016
26072016Bridging non-human primate correlates of protection to reassess the Anthrax Vaccine Adsorbed booster schedule in humans.Vaccine2015
26703716Ebola Virus Infections in Nonhuman Primates Are Temporally Influenced by Glycoprotein Poly-U Editing Site Populations in the Exposure Material.Viruses2015
25185577Comprehensive analysis and selection of anthrax vaccine adsorbed immune correlates of protection in rhesus macaques.Clin Vaccine Immunol2014
23397329Accumulation of CD11b⁺Gr-1⁺ cells in the lung, blood and bone marrow of mice infected with highly pathogenic H5N1 and H1N1 influenza viruses.Arch Virol2013
22933399A three-dose intramuscular injection schedule of anthrax vaccine adsorbed generates sustained humoral and cellular immune responses to protective antigen and provides long-term protection against inhalation anthrax in rhesus macaques.Clin Vaccine Immunol2012
22074594Conserved host response to highly pathogenic avian influenza virus infection in human cell culture, mouse and macaque model systems.BMC Syst Biol2011
20372944Extrapulmonary tissue responses in cynomolgus macaques (Macaca fascicularis) infected with highly pathogenic avian influenza A (H5N1) virus.Arch Virol2010
20844032Macaque proteome response to highly pathogenic avian influenza and 1918 reassortant influenza virus infections.J Virol2010
20739500Vaccination of rhesus macaques with the anthrax vaccine adsorbed vaccine produces a serum antibody response that effectively neutralizes receptor-bound protective antigen in vitro.Clin Vaccine Immunol2010
19218453Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virus.Proc Natl Acad Sci U S A2009
19383786Antigen-specific Vgamma2Vdelta2 T effector cells confer homeostatic protection against pneumonic plaque lesions.Proc Natl Acad Sci U S A2009
19526566Upregulation of gamma-2 laminin-332 in the mouse ear vesicant wound model.J Biochem Mol Toxicol2009
17531433Transcriptional responses in spleens from mice exposed to Yersinia pestis CO92.Microb Pathog2007
17897215Formaldehyde gas inactivation of Bacillus anthracis, Bacillus subtilis, and Geobacillus stearothermophilus spores on indoor surface materials.J Appl Microbiol2007
16377760Microarray analysis of mouse ear tissue exposed to bis-(2-chloroethyl) sulfide: gene expression profiles correlate with treatment efficacy and an established clinical endpoint.J Pharmacol Exp Ther2006
18958681Evaluation of Acute Immunotoxicity of Aerosolized Aflatoxin B(1) in Female C57BL/6N Mice.J Immunotoxicol2006
16489579Preferential expression of matrix metalloproteinase-9 in mouse skin after sulfur mustard exposure.J Appl Toxicol2006
16494973Transcriptional analysis of protective antigen-stimulated PBMC from non-human primates vaccinated with the anthrax vaccine absorbed.Vaccine2006
16162224Decontamination assessment of Bacillus anthracis, Bacillus subtilis, and Geobacillus stearothermophilus spores on indoor surfaces using a hydrogen peroxide gas generator.J Appl Microbiol2005
15388249Localization of substance P gene expression for evaluating protective countermeasures against sulfur mustard.Toxicology2004
15674844Time- and dose-dependent analysis of gene expression using microarrays in sulfur mustard-exposed mice.J Biochem Mol Toxicol2004
15674843Microarray analysis of gene expression in murine skin exposed to sulfur mustard.J Biochem Mol Toxicol2004
12481301Cytokine, chemokine, and matrix metalloproteinase response after sulfur mustard injury to weanling pig skin.J Biochem Mol Toxicol2002
11301476Chromosome 3p tumor-suppressor gene alterations in cervical carcinomas.Mol Carcinog2001
11193761The role of CC10 in pulmonary carcinogenesis: from a marker to tumor suppression.Ann N Y Acad Sci2000
11083082Alterations in inflammatory cytokine gene expression in sulfur mustard-exposed mouse skin.J Biochem Mol Toxicol2000
9863006Altered localization of E-cadherin and alpha-catenin in rat esophageal tumors.Int J Oncol1999
10334207Expression of cytochrome P450 2A3 in rat esophagus: relevance to N-nitrosobenzylmethylamine.Carcinogenesis1999
10536181Peroxisome proliferator-activated receptor gamma activation in human breast cancer.Int J Oncol1999
9855016Altered expression of cyclin D1 and cyclin-dependent kinase 4 in azoxymethane-induced mouse colon tumorigenesis.Carcinogenesis1998
9458357p53-independent down-regulation of cyclin D1 and p21Waf1 in the process of immortalization of human esophageal epithelial cells.Int J Oncol1998
9659580Expression of cell cycle proteins in 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced mouse lung tumors.Exp Lung Res1998
9537650Alterations in the expression of alpha6beta4 integrin and p21/WAF1/Cip1 in N-nitrosomethylbenzylamine-induced rat esophageal tumorigenesis.Mol Carcinog1998
9127380Mutated and wild-type p53 expression and HPV integration in proliferative verrucous leukoplakia and oral squamous cell carcinoma.Oral Surg Oral Med Oral Pathol Oral Radiol Endod1997
8599581Alterations in transforming growth factor-alpha and epidermal growth factor receptor expression during rat esophageal tumorigenesis.Mol Carcinog1996
  • 1 - 50 of 77

Recommended Authors

and Lineberger Comprehensive Cancer Center, University of North Carolina System
Career Start Year 2006
Number of shared co-authors 1
University of Michigan ann arbor
Career Start Year 2000
Number of shared co-authors 0
Keck School of Medicine of USC, University of Southern
Career Start Year 1999
Number of shared co-authors 0
College of Science & Industry Convergence, Ewha Womans University
Career Start Year 1997
Number of shared co-authors 0
Pondicherry University
Career Start Year 1997
Number of shared co-authors 2
University of California San Diego
Career Start Year 1994
Number of shared co-authors 0
Caryl and Israel Englander Institute for Precision Medicine.
Career Start Year 1993
Number of shared co-authors 0
Cincinnati Children's Hospital
Career Start Year 1989
Number of shared co-authors 0
Universidade Federal de Santa Maria
Career Start Year 1988
Number of shared co-authors 0
National Institute of Environmental Health Sciences
Career Start Year 1988
Number of shared co-authors 0
University of Cape Town
Career Start Year 1988
Number of shared co-authors 0
Philip Morris International Research Laboratories Pte. Ltd
Career Start Year 1987
Number of shared co-authors 0
University of Alabama at Birmingham
Career Start Year 1987
Number of shared co-authors 0
Moffitt Cancer Center
Career Start Year 1986
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1986
Number of shared co-authors 0
Institute for Research in Immunology and Cancer (IRIC), University of Montreal
Career Start Year 1986
Number of shared co-authors 0
Hoag Memorial Hospital Presbyterian
Career Start Year 1983
Number of shared co-authors 1
Center for Molecular Imaging, University of Pittsburgh School of Medicine
Career Start Year 1981
Number of shared co-authors 0
Oregon Health & Science University
Career Start Year 1980
Number of shared co-authors 1
University of Alabama
Career Start Year 1979
Number of shared co-authors 0
The University of Notre Dame Australia
Career Start Year 1979
Number of shared co-authors 0
Boston Children's Hospital
Career Start Year 1978
Number of shared co-authors 0
University of Alabama at Birmingham
Career Start Year 1978
Number of shared co-authors 0
Center for Future Medical Research, Tokyo Medical University
Career Start Year 1975
Number of shared co-authors 0
The Wistar Institute
Career Start Year 1975
Number of shared co-authors 0
St. Jude Children's Research Hospital
Career Start Year 1975
Number of shared co-authors 0
University of Alabama at Birmingham
Career Start Year 1974
Number of shared co-authors 0
University of Texas Medical School at Houston
Career Start Year 1973
Number of shared co-authors 0
Enterin Research Institute Inc.
Career Start Year 1969
Number of shared co-authors 0
National Centre for Asbestos Related Diseases, University of Western Australia
Career Start Year 1967
Number of shared co-authors 0

Collaborators

University of Washington
Co-authored papers 5
University of Texas M.D. Anderson Cancer Center
Co-authored papers 5
Icahn School of Medicine at Mount Sinai
Co-authored papers 4
Icahn School of Medicine at Mount Sinai
Co-authored papers 4
Centers for Disease Control and Prevention
Co-authored papers 4
Centers for Disease Control and Prevention.
Co-authored papers 3
US Centers for Disease Control and Prevention COVID-19 Response Team
Co-authored papers 2
Pacific Northwest National Laboratory
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Centers for Disease Control and Prevention
Co-authored papers 2
Pacific Northwest National Laboratory
Co-authored papers 1
University of Washington
Co-authored papers 1
University of Chicago, Gwen Knapp Center for Lupus Research.
Co-authored papers 1
Pacific Northwest National Laboratory
Co-authored papers 1
Co-authored papers 1
Pacific Northwest National Laboratory
Co-authored papers 1
Influenza Research Institute, University of Wisconsin-Madison
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Oregon Health & Science University, University of California Berkeley
Co-authored papers 1
Co-authored papers 1
Fred Hutchinson Cancer Research Center
Co-authored papers 1
Mayo Clinic Vaccine Research Group
Co-authored papers 1
Co-authored papers 1
Merck & Co.
Co-authored papers 1
Harbin Veterinary Research Institute
Co-authored papers 1
Influenza Research Institute, University of Wisconsin
Co-authored papers 1
Clinical Research Division, Fred Hutchinson Cancer Research Center
Co-authored papers 1